RMTG Partners with BKFC as Official Regenerative Medicine Provider
Regenerative Medical Technologies Group (OTCID:RMTG) has announced a strategic partnership with Bare Knuckle Fighting Championship (BKFC) to become their official stem cell and regenerative medicine provider. The partnership aims to provide advanced treatments for fighters' sport-related injuries.
The collaboration addresses a critical need in combat sports, where fighters face high injury rates - 28-40 injuries per 100 fight participations, with facial lacerations (48%), hand injuries (13.5%), and nose injuries (10.4%) being most common. RMTG's stem cell therapies promise to cut healing time in half compared to traditional methods, while offering enhanced tissue regeneration and reduced inflammation.
This partnership with the world's fastest-growing combat sports league positions RMTG to showcase its regenerative medicine solutions to mainstream audiences and potentially expand into broader professional athletics markets.
Regenerative Medical Technologies Group (OTCID:RMTG) ha annunciato una partnership strategica con Bare Knuckle Fighting Championship (BKFC) per diventare il fornitore ufficiale di cellule staminali e medicina rigenerativa. L’obiettivo è offrire trattamenti avanzati per gli infortuni sportivi dei combattenti. La collaborazione risponde a un’esigenza cruciale nelle arti marziali da combattimento, dove gli infortuni sono elevati: 28-40 infortuni ogni 100 partecipazioni a combattimento, con tra le più comuni ferite facciali (48%), infortuni alle mani (13,5%) e al naso (10,4%). Le terapie a base di cellule staminali di RMTG promettono di dimezzare i tempi di guarigione rispetto ai metodi tradizionali, offrendo al contempo una rigenerazione tissutale migliorata e una riduzione dell’infiammazione. Questa partnership con la lega di sport da combattimento in più rapida crescita al mondo posiziona RMTG per mostrare le proprie soluzioni di medicina rigenerativa a un pubblico mainstream e potenzialmente espandersi in mercati più ampi dell’atletica professionistica.
Regenerative Medical Technologies Group (OTCID:RMTG) ha anunciado una alianza estratégica con Bare Knuckle Fighting Championship (BKFC) para convertirse en su proveedor oficial de células madre y medicina regenerativa. El objetivo es ofrecer tratamientos avanzados para las lesiones deportivas de los peleadores. La colaboración atiende una necesidad crítica en los deportes de combate, donde los peleadores presentan altas tasas de lesiones: 28-40 lesiones por cada 100 participaciones en combates, siendo las laceraciones faciales (48%), las lesiones en las manos (13,5%) y las lesiones nasales (10,4%) las más comunes. Las terapias con células madre de RMTG prometen reducir a la mitad el tiempo de curación respecto a métodos tradicionales, además de mejorar la regeneración de tejidos y disminuir la inflamación. Esta asociación con la liga de deportes de combate de más rápido crecimiento del mundo sitúa a RMTG para mostrar sus soluciones de medicina regenerativa ante audiencias masivas y podría expandirse a mercados más amplios de atletismo profesional.
Regenerative Medical Technologies Group (OTCID:RMTG)가 Bare Knuckle Fighting Championship (BKFC)와 전략적 파트너십을 발표하여 공식 줄기세포 및 재생의학 공급업체로 자리매김합니다. 이 파트너십은 선수들의 스포츠 부상에 대한 첨단 치료를 제공하는 것을 목표로 합니다. 전투 스포츠에서 필요한 협력은 중요한데, 부상률이 높으며 전투 참가 100회당 28-40건의 부상, 가장 흔한 부상으로 안면 베임(48%), 손 부상(13.5%), 코 부상(10.4%)이 꼽힙니다. RMTG의 줄기세포 치료는 전통적 방법에 비해 치유 시간을 절반으로 단축하고 조직 재생을 강화하며 염증을 감소시킬 약속이 있습니다. 세계에서 가장 빠르게 성장하는 전투 스포츠 리그와의 이 파트너십은 RMTG가 재생의학 솔루션을 대중들에게 선보이고 더 넓은 프로 atletics 시장으로 확장할 수 있는 위치를 제공합니다.
Regenerative Medical Technologies Group (OTCID:RMTG) a annoncé un partenariat stratégique avec Bare Knuckle Fighting Championship (BKFC) pour devenir leur fournisseur officiel de cellules souches et de médecine régénérative. Le partenariat vise à proposer des traitements avancés pour les blessures liées au sport chez les combattants. Cette collaboration répond à un besoin crucial dans les sports de combat, où les taux de blessure sont élevés — 28-40 blessures pour 100 participations à des combats, les coupures faciales (48%), les blessures à la main (13,5%) et au nez (10,4%) étant les plus fréquentes. Les thérapies à base de cellules souches de RMTG promettent de réduire de moitié le temps de guérison par rapport aux méthodes traditionnelles, tout en offrant une meilleure régénération des tissus et une réduction de l’inflammation. Ce partenariat avec la ligue de sports de combat à la croissance la plus rapide au monde positionne RMTG pour présenter ses solutions de médecine régénérative à un public grand public et potentiellement s’étendre à des marchés plus vastes de l’athlétisme professionnel.
Regenerative Medical Technologies Group (OTCID:RMTG) hat eine strategische Partnerschaft mit Bare Knuckle Fighting Championship (BKFC) bekannt gegeben, um offizieller Anbieter von Stammzellen und regenerativer Medizin zu werden. Die Partnerschaft zielt darauf ab, fortschrittliche Behandlungen für sportbedingte Verletzungen von Kämpfern bereitzustellen. Die Zusammenarbeit spricht einen kritischen Bedarf im Kampfsport an, wo Kämpfer hohe Verletzungsraten haben — 28-40 Verletzungen pro 100 Kämpfe, wobei Gesichtsverletzungen (48%), Handverletzungen (13,5%) und Nasenverletzungen (10,4%) am häufigsten sind. Die Stammzelltherapien von RMTG versprechen, die Heilungsdauer im Vergleich zu traditionellen Methoden zu halbieren, bei gleichzeitiger besseren Geweberegeneration und reduzierter Entzündung. Diese Partnerschaft mit der weltweit am schnellsten wachsenden Kampfsportliga positioniert RMTG, um seine regenerativen Medizinlösungen einem Mainstream-Publikum zu präsentieren und möglicherweise in breitere professionelle Athletikmärkte zu expandieren.
Regenerative Medical Technologies Group (OTCID:RMTG) أعلنت عن شراكة استراتيجية مع Bare Knuckle Fighting Championship (BKFC) لتصبح موردها الرسمي للخلايا الجذعية والطب التجديدي. تستهدف الشراكة توفير علاجات متقدمة لإصابات الرياضيين في القتال. تلبي التعاون حاجة حاسمة في رياضات القتال، حيث ترتفع معدلات الإصابات — 28-40 إصابة لكل 100 مشاركة في القتال، وأصبحت الشقوق الوجهية (48%)، إصابات اليد (13.5%)، وإصابات الأنف (10.4%) من الأكثر شيوعاً. تعد علاجات الخلايا الجذعية من RMTG بتقليل وقت الشفاء إلى النصف مقارنة بالأساليب التقليدية، مع تحسين regeneración os tejidos وتقليل الالتهاب. هذه الشراكة مع أسرع دوري رياضات قتالية نمواً في العالم تُمكّن RMTG من عرض حلول الطب التجديدي للجمهور العام وربما التوسع في أسواق الرياضة المهنية الأوسع.
Regenerative Medical Technologies Group (OTCID:RMTG) 已宣布与Bare Knuckle Fighting Championship (BKFC)建立战略伙伴关系，成为其官方干细胞与再生医学供应商。该合作旨在为战斗运动员的运动相关伤病提供前沿治疗。此举回应了搏击运动中的关键需求，伤病率较高——每100次比赛参与中有28-40起伤病，其中面部割伤（48%）、手部伤害（13.5%）和鼻部伤害（10.4%）最为常见。RMTG的干细胞疗法承诺将康复时间比传统方法缩短一半，同时提升组织再生并降低炎症。与全球增长最快的格斗体育联盟的合作将使RMTG有机会向主流观众展示其再生医学解决方案，并可能扩展至更广泛的职业体育市场。
- Partnership with BKFC provides high-visibility exposure in mainstream sports medicine market
- Technology offers 50% faster healing time compared to traditional treatments
- Strategic positioning to expand into broader professional athletics markets
- Addresses a documented high-need market with 28-40 injuries per 100 fight participations
- None.
Combat Sports Partnership Brings Advanced Stem Cell Treatments to Elite Fighters
LAS VEGAS, NEVADA / ACCESS Newswire / September 29, 2025 / Regenerative Medical Technologies Group, Inc. (the "Company") (OTCID:RMTG), a global leader in regenerative medicine solutions, announces a new strategic partnership with Bare Knuckle Fighting Championship (BKFC) to serve as the league's official stem cell and regenerative medicine provider for treating fighters' sport-related injuries.
Why Fighters Need These Treatments:
Combat sports athletes face brutal physical demands. Research shows MMA fighters experience approximately 28-40 injuries per 100 fight participations, with facial lacerations accounting for nearly
RMTG's stem cell therapies can offer a game-changing solution - faster healing, reduced inflammation, and tissue regeneration that gets fighters back in action quicker while protecting their long-term health.
Partnership Benefits:
Faster Recovery: Stem cell treatments can cut healing time in half compared to traditional methods
Career Protection: Advanced therapies preserve joint health and extend fighting careers
Pain Reduction: Natural healing that addresses root causes, not just symptoms
Performance Enhancement: Better tissue quality means improved athletic output
"We are very pleased to partner with RMTG to provide the best Stem Cell services for our fighters at BKFC. RMTG is a leader in this field, and we look forward to giving the BKFC Fighters the best healing options possible. Thank you to RMTG for allowing us to partner with the best in the business." David Feldman, President of BKFC
"This partnership with BKFC brings the future of medicine to the toughest athletes on the planet," said David Christensen, CEO of RMTG. "These fighters put everything on the line, and our regenerative medicine gives them the best tools available to recover faster and fight longer."
GSCG CEO Benito Novas said: "Listen, I've been in this industry long enough to know that recovery is everything. The punishment that MMA fighters take is unreal - bare knuckle fighting especially. These stem cell treatments, this regenerative medicine - it's the future of sports medicine. When you're putting your body through what we put it through, you need every advantage you can get. RMTG & GSCG are bringing real science to help fighters not just survive, but dominate. This is next-level medicine for next-level warriors."
Market Opportunity:
BKFC is the world's fastest growing combat sports league, providing RMTG with high-visibility exposure to mainstream audiences. The partnership is designed to bring awareness to these audiences of the benefits of regenerative medicine over traditional forms of sports medicine and open doors across professional athletics where recovery and performance optimization are critical.
About RMTG:
RMTG operates through its Global Stem Cells Group subsidiary across more than 30 countries, distributing regenerative medicine solutions worldwide while specializing in physician education through its ISSCA platform. The Company's integrated approach combines clinical operations, product distribution, manufacturing capabilities, and medical education to capitalize on the rapidly expanding global regenerative medicine market. To learn more, visit www.stemcellsgroup.com.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
Some information in this document constitutes forward-looking statements or statements which may be deemed or construed to be forward-looking statements, such as the arrangement agreed upon with Bare Knuckle Fighting Championship. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission and they include the risk that the Company will not meet expectations regarding the intended benefits, market opportunities, or financial results, associated with its arrangement with Bare Knuckle Fighting Championship. All forward-looking statements attributable to Regenerative Medical Technologies Group, Inc., herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Regenerative Medical Technologies Group, Inc. disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
Contact:
David Christensen,
CEO Regenerative Medical Technologies Group, Inc.
investor.relations@regenmedtechgroup.com | (800) 956-3935
SOURCE: Regenerative Medical Technology Group
View the original press release on ACCESS Newswire
FAQ
What is the new partnership between RMTG and BKFC?
How common are injuries in combat sports that RMTG will treat?
What are the main benefits of RMTG's stem cell treatments for BKFC fighters?
How will the BKFC partnership impact RMTG's market position?
Who are the key executives involved in the RMTG-BKFC partnership?
